These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3141427)

  • 1. Effects of fosfomycin, mesna, and sodium thiosulfate on the toxicity and antitumor activity of cisplatin.
    Wagner T; Kreft B; Bohlmann G; Schwieder G
    J Cancer Res Clin Oncol; 1988; 114(5):497-501. PubMed ID: 3141427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia.
    Howell SB; Taetle R
    Cancer Treat Rep; 1980; 64(4-5):611-6. PubMed ID: 7191778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesna does not reduce cisplatin induced nephrotoxicity in the rat.
    Millar BC; Siddik ZH; Millar JL; Jinks S
    Cancer Chemother Pharmacol; 1985; 15(3):307-9. PubMed ID: 3931929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between cisplatin and mesna in mice.
    Dorr RT; Lagel K
    J Cancer Res Clin Oncol; 1989; 115(6):604-5. PubMed ID: 2514188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection by sodium thiosulfate and thiourea against lethal toxicity of cis-diamminedichloroplatinum (II) in bacteria and mice.
    Ishizawa M; Taniguchi S; Baba T
    Jpn J Pharmacol; 1981 Dec; 31(6):883-9. PubMed ID: 6801366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of sodium-2-mercaptoethanesulfonate on the gastrointestinal toxicity and lethality of cis-diamminedichloroplatinum.
    Allan SG; Smyth JF; Hay FG; Leonard RC; Wolf CR
    Cancer Res; 1986 Jul; 46(7):3569-73. PubMed ID: 3085925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on hemotoxicity of cyclophosphamide, doxorubicin and cis-diamminodichloroplatinum combined with sodium-2-mercaptoethane sulfonate.
    Lerza R; Bogliolo G; Mencoboni M; Saviane A; Pannacciulli I
    Tumori; 1988 Jun; 74(3):333-7. PubMed ID: 3135644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity.
    Church MW; Kaltenbach JA; Blakley BW; Burgio DL
    Hear Res; 1995 Jun; 86(1-2):195-203. PubMed ID: 8567417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin combined with tiopronin or sodium thiosulfate: cytotoxicity in vitro and antitumor activity in vivo.
    Viale M; Zhang JG; Pastrone I; Mariggiò MA; Esposito M; Lindup WE
    Anticancer Drugs; 1999 Apr; 10(4):419-28. PubMed ID: 10378678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reduction of cisplatin toxicity by fosfomycin in animal models].
    Ohtani I; Ohtsuki K; Aikawa T; Sato Y; Anzai T; Ouchi J; Saito T
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2400-7. PubMed ID: 6541892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reaction kinetics of cisplatin and its monoaquated species with the modulating agents (di)mesna and thiosulphate.
    Leeuwenkamp OR; Neijt JP; van der Vijgh WJ; Pinedo HM
    Eur J Cancer; 1991; 27(10):1243-7. PubMed ID: 1835593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of sodium thiosulfate on subcellular localization of platinum in rat kidney after treatment with cisplatin.
    Uozumi J; Litterst CL
    Cancer Lett; 1986 Sep; 32(3):279-83. PubMed ID: 3768854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective prevention of the nephrotoxicity of cis-platin (CDDP) by administration of sodium 2-mercaptoethane-sulfonate (MESNA) in rats.
    Kempf SR; Ivankovic S; Wiessler M; Schmähl D
    Br J Cancer; 1985 Dec; 52(6):937-9. PubMed ID: 3935152
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
    Dickey DT; Wu YJ; Muldoon LL; Neuwelt EA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1052-8. PubMed ID: 15951398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts.
    Boven E; Verschraagen M; Hulscher TM; Erkelens CA; Hausheer FH; Pinedo HM; van der Vijgh WJ
    Eur J Cancer; 2002 May; 38(8):1148-56. PubMed ID: 12008205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.
    DeWoskin RS; Riviere JE
    Toxicol Appl Pharmacol; 1992 Feb; 112(2):182-9. PubMed ID: 1311464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reaction kinetics of cisplatin and its monoaquated species with the (potential) renal protecting agents (di)mesna and thiosulfate. Estimation of the effect of protecting agents on the plasma and peritoneal AUCs of CDDP.
    Leeuwenkamp OR; van der Vijgh WJ; Neijt JP; Pinedo HM
    Cancer Chemother Pharmacol; 1990; 27(2):111-4. PubMed ID: 2174306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of mesna and cysteine on the systemic toxicity and therapeutic efficacy of activated cyclophosphamide.
    Wagner T; Zink M; Schwieder G
    J Cancer Res Clin Oncol; 1987; 113(2):160-5. PubMed ID: 3104347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity and carcinogenic risk of cis-platin (CDDP) prevented by sodium 2-mercaptoethane-sulfonate (Mesna): experimental results.
    Kempf SR; Ivankovic S
    Cancer Treat Rev; 1987 Dec; 14(3-4):365-72. PubMed ID: 3125972
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats.
    Verschraagen M; Boven E; Torun E; Erkelens CA; Hausheer FH; van der Vijgh WJ
    Br J Cancer; 2004 Apr; 90(8):1654-9. PubMed ID: 15083199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.